Introduction: Antibody Libraries, Phage Scaffolds, and Therapeutic Discovery Pipelines Antibodies are the cornerstone of modern biologics. From checkpoint inhibitors and bispecifics to antibody-drug conjugates (ADCs), they dominate the therapeutic pipeline across oncology, autoimmune disease, infectious disease, and rare disorders. Yet the success of any antibody program hinges on the ability to discover high-affinity, high-specificity binders—molecules […]